» Articles » PMID: 16611897

Base Pairing Between the 5' Half of Epsilon and a Cis-acting Sequence, Phi, Makes a Contribution to the Synthesis of Minus-strand DNA for Human Hepatitis B Virus

Overview
Journal J Virol
Date 2006 Apr 14
PMID 16611897
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Synthesis of minus-strand DNA of human hepatitis B virus (HBV) can be divided into three phases: initiation of DNA synthesis, the template switch, and elongation of minus-strand DNA. Although much is known about minus-strand DNA synthesis, the mechanism(s) by which this occurs has not been completely elucidated. Through a deletion analysis, we have identified a cis-acting element involved in minus-strand DNA synthesis that lies within a 27-nucleotide region between DR2 and the 3' copy of DR1. A subset of this region (termed Phi) has been hypothesized to base pair with the 5' half of epsilon (H. Tang and A. McLachlan, Virology, 303:199-210, 2002). To test the proposed model, we used a genetic approach in which multiple sets of variants that disrupted and then restored putative base pairing between the 5' half of epsilon and phi were analyzed. Primer extension analysis, using two primers simultaneously, was performed to measure encapsidated pregenomic RNA (pgRNA) and minus-strand DNA synthesized in cell culture. The efficiency of minus-strand DNA synthesis was defined as the amount of minus-strand DNA synthesized per encapsidation event. Our results indicate that base pairing between phi and the 5' half of epsilon contributes to efficient minus-strand DNA synthesis. Additional results are consistent with the idea that the primary sequence of phi and/or epsilon also contributes to function. How base pairing between phi and epsilon contributes to minus-strand DNA synthesis is not known, but a simple speculation is that phi base pairs with the 5' half of epsilon to juxtapose the donor and acceptor sites to facilitate the first-strand template switch.

Citing Articles

Structural Analysis of the Hepatitis B Virus RNA Encapsidation Signal ε by Selective 2'-Hydroxyl Acylation Analyzed by Primer Extension (SHAPE).

Dornbrack K, Beck J, Nassal M Methods Mol Biol. 2024; 2837:67-87.

PMID: 39044076 DOI: 10.1007/978-1-0716-4027-2_7.


Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target.

Olenginski L, Attionu S, Henninger E, LeBlanc R, Longhini A, Dayie T Viruses. 2023; 15(9).

PMID: 37766319 PMC: 10534774. DOI: 10.3390/v15091913.


Relaxing the restricted structural dynamics in the human hepatitis B virus RNA encapsidation signal enables replication initiation in vitro.

Dornbrack K, Beck J, Nassal M PLoS Pathog. 2022; 18(3):e1010362.

PMID: 35259189 PMC: 8903280. DOI: 10.1371/journal.ppat.1010362.


Pathogenicity and virulence of Hepatitis B virus.

Chuang Y, Tsai K, Ou J Virulence. 2022; 13(1):258-296.

PMID: 35100095 PMC: 8812780. DOI: 10.1080/21505594.2022.2028483.


DNA Engineering and Hepatitis B Virus Replication.

Gan C, Cui J, Zhang W, Wang Y, Huang A, Hu J Front Microbiol. 2021; 12:783040.

PMID: 34858381 PMC: 8632529. DOI: 10.3389/fmicb.2021.783040.


References
1.
Summers J, Mason W . Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell. 1982; 29(2):403-15. DOI: 10.1016/0092-8674(82)90157-x. View

2.
Pollack J, Ganem D . An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol. 1993; 67(6):3254-63. PMC: 237666. DOI: 10.1128/JVI.67.6.3254-3263.1993. View

3.
Tuttleman J, Pourcel C, Summers J . Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986; 47(3):451-60. DOI: 10.1016/0092-8674(86)90602-1. View

4.
Wang G, Seeger C . Novel mechanism for reverse transcription in hepatitis B viruses. J Virol. 1993; 67(11):6507-12. PMC: 238087. DOI: 10.1128/JVI.67.11.6507-6512.1993. View

5.
Liu N, Tian R, Loeb D . Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. Proc Natl Acad Sci U S A. 2003; 100(4):1984-9. PMC: 149945. DOI: 10.1073/pnas.0436218100. View